Ningzhi Chen focuses on advising clients on a wide range of capital markets transactions, particularly in Hong Kong IPOs. She also advises public companies on their general corporate compliance matters, and advises Chinese and international financial institutions and borrowers on corporate finance transactions.
Prior to joining the firm, Ningzhi worked in capital markets, corporate, and banking & finance groups of a leading “magic circle” firm.
Hong Kong IPOs
- CICC as sole sponsor and 20 other underwriters in approximately US$85 million IPO of Shanghai Voicecomm Information Technology Co., Ltd. on the Hong Kong Stock Exchange
- Laopu Gold Co., Ltd. in its approximately US$116 million IPO and listing on the Hong Kong Stock Exchange
- Shanghai Bio-heart Biological Technology Co., Ltd. in its US$65.3 million IPO and listing on the Hong Kong Stock Exchange
- Yonghe Medical Group Co., Ltd. in its US$206 million IPO and listing on the Hong Kong Stock Exchange
- Acotec Scientific Holdings Limited in its US$210 million IPO and listing on the Hong Kong Stock Exchange
- Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
- Maoyan Entertainment in its US$250 million IPO and listing on the Hong Kong Stock Exchange
- China Kepei Education Group Limited in its US$112 million IPO and listing on the Hong Kong Stock Exchange
- Goldman Sachs (Asia) L.L.C., Morgan Stanley Asia Limited, and CLSA Capital Markets Limited as joint sponsors and other underwriters in the US$5.4 billion IPO and listing of Xiaomi Corporation on the Hong Kong Stock Exchange
- ABCI Capital Limited and Guotai Junan Capital Limited as joint sponsors and other underwriters in the US$255.66 million IPO and listing of China Tianbao Group Development Company Limited on the Hong Kong Stock Exchange
Corporate Compliance
- Various companies including China Construction Bank, China Everbright Bank, China CITIC Financial Asset Management Co., Ltd., China Machinery Engineering Corporation, China Energy Engineering Corporation, Kangning Hospital, etc.
Corporate Finance
- Credit Suisse AG in the US$550 million facility and US$240 million facility granted to PRC borrowers for financing of assets acquisition
- PRC borrower in the US$300 million facility granted by Citibank, China Construction Bank (Asia), and China Industrial Securities International
- China Development Bank in the US$150 million facility granted to Muscat Bank SAOG for supporting the development of small businesses and green projects in Oman
- International Finance Corporation (IFC) and Deutsche Investitions- und Entwicklungsgesellschaft mbH (DEG) in the up to US$112 million parallel loans granted to PRC borrowers
- CCBT Frontier Capital (Hong Kong) Limited in the US$50 million perpetual loan granted to a Hong Kong borrower for financing of stock acquisition
- HOPU in the US$36 million facility granted by DBS Bank
Languages
- Mandarin Chinese
- English
Admissions
- New York
Education
- University of California, Berkeley, LL.M.
- China University of Political Science and Law, LL.B.; B.A., English Language and Literature
Professional Activities
Bar Admissions
- Passed Chinese Bar Exam
Related Practices
Related Regions